Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stroke

Long-term outcome of endovascular therapy for ischaemic stroke

Nature Reviews Neurology volume 13, pages 387–388 (2017)Cite this article

Subjects

In patients with acute ischaemic stroke resulting from anterior circulation occlusion, endovascular therapy provides greater long-term benefits than does intravenous tissue plasminogen activator. However, further improvement of systems of care and research regarding adjunct therapies is still needed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Endovascular treatment in acute ischaemic stroke.

References

  1. Berkhemer, O. A., van Zwam, W. H. & Dippel, D. W. Stent-retriever thrombectomy for stroke. N. Engl. J. Med. 373, 1076 (2015).

    Article  CAS  PubMed  Google Scholar 

  2. Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387, 1723–1731 (2016).

    Article  PubMed  Google Scholar 

  3. van den Berg, L. A. et al. Two-year outcome after endovascular treatment for acute ischemic stroke. N. Engl. J. Med. 376, 1341–1349 (2017).

    Article  PubMed  Google Scholar 

  4. Davalos, A. et al. Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial. Lancet Neurol. 16, 369–376 (2017).

    Article  PubMed  Google Scholar 

  5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581–1587 (1995).

  6. Kwiatkowski, T. G. et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N. Engl. J. Med. 340, 1781–1787 (1999).

    Article  CAS  PubMed  Google Scholar 

  7. Sajobi, T. T. et al. Early Trajectory of stroke severity predicts long-term functional outcomes in ischemic stroke subjects: results from the ESCAPE trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times). Stroke 48, 105–110 (2017).

    Article  CAS  PubMed  Google Scholar 

  8. Rapport, F. et al. The struggle of translating science into action: foundational concepts of implementation science. J. Eval. Clin. Pract. http:dx.doi.org/10.1111/jep.12741 (2017).

  9. Shireman, T. I. et al. Cost-effectiveness of solitaire stent retriever thrombectomy for acute ischemic stroke: results from the SWIFT-PRIME trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke). Stroke 48, 379–387 (2017).

    Article  PubMed  Google Scholar 

  10. Holodinsky, J. K. et al. Drip and ship versus direct to comprehensive stroke center: conditional probability modeling. Stroke 48, 233–238 (2017).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charlotte Zerna and Mayank Goyal are at the Seaman Family Magnetic Resonance Research Centre, Foothills Medical Centre, 1403 29th Street NW, Calgary, Alberta T2N 2T9, Canada.,

    Charlotte Zerna & Mayank Goyal

Authors
  1. Charlotte Zerna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mayank Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mayank Goyal.

Ethics declarations

Competing interests

M.G. declares grant support from Covidien, consulting fees from Medtronic and Stryker, and grant support from GE Healthcare. C.Z. declares no competing interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zerna, C., Goyal, M. Long-term outcome of endovascular therapy for ischaemic stroke. Nat Rev Neurol 13, 387–388 (2017). https://doi.org/10.1038/nrneurol.2017.78

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2017.78

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing